Key result
Early palliative care in advanced CVD improves quality of life and reduces low-value end-of-life care.
Why the study?
Outside of heart failure populations, gaps in widespread palliative care implementation across populations supported with cardiac devices and diverse cultural and health systems remain.
Does palliative care improve quality of life and symptom control in adults with advanced cardiovascular disease?
Does palliative care improve quality of life and symptom control in adults with advanced cardiovascular disease?
This state-of-the-art review highlights the benefits of integrating palliative care in cardiovascular medicine to improve symptom management and quality of life, while identifying ongoing implementation gaps.
Answers are grounded in this paper and cite their sources.
Warrants early palliative care integration in advanced CVD; extends evidence to cardiovascular populations while highlighting implementation gaps.
Cardiovascular disease remains the leading global cause of morbidity and mortality. Although advances in prevention, diagnostics, and disease-modifying therapies have prolonged survival, many individuals now live longer with high symptom burden, functional decline, and complex decisional needs. Palliative care (PC) for adults with advanced cardiovascular disease can improve quality of life, support caregivers, and align treatments with patient values and goals. Core elements include symptom management, effective communication, shared decision-making, advance care planning, and integration of psychosocial and spiritual support across the disease trajectory and different care settings. Current evidence demonstrates that early PC intervention can improve symptom control, enhance quality of life, reduce psychological distress, and decrease high-intensity yet low-value care near the end of life. Nevertheless, outside of heart failure populations, gaps in widespread PC implementation across populations supported with cardiac devices as well as across diverse cultural and health systems remain. This state-of-the-art review (i) synthesizes conceptual foundations, referral triggers, and delivery models for PC in cardiovascular medicine; (ii) reviews disease-specific considerations across heart failure, valvular disease, pulmonary hypertension, arrhythmias, and congenital heart disease; (iii) outlines ethical and legal issues including advance directives and device deactivation; (iv) provides practical guidance for symptom management and communication frameworks; and (v) proposes a pragmatic algorithm to support clinical integration of PC into cardiovascular medicine.
No takes yet. Share an insight, caveat, or question.
Cekaj et al. (2026) studied this question. Early palliative care in advanced cardiovascular disease improves symptom control, enhances quality of life, and decreases high-intensity, low-value care near the end of life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: